Sophiris stock


Sophiris Bio Inc. (SPHS) Shines Light on Topsalysin Phase 2b Enrollment in Localized Prostate Cancer

Sophiris Bio Inc (NASDAQ:SPHS) provided an update on clinical trial enrollment of its Phase 2b study of topsalysin as a treatment for men …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts